Soleus Capital Management, L.P. Pacira Bio Sciences, Inc. Transaction History

Soleus Capital Management, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $1.15 Million - $1.82 Million	-22,250 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $4.76 Million - $6.07 Million	-79,350 Reduced 78.1%	22,250 $1.7 Million
Q4 2021 Feb 14, 2022	BUY	$47.97 - $62.21 $1.71 Million - $2.21 Million	35,600 Added 53.94%	101,600 $6.11 Million
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $3.61 Million - $4.05 Million	66,000 New	66,000 $3.7 Million
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $514,794 - $675,852	-10,200 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $103,940 - $126,000	-2,000 Reduced 16.39%	10,200 $613,000
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $160,160 - $272,844	5,200 Added 74.29%	12,200 $640,000
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $198,800 - $354,900	7,000 New	7,000 $235,000

258

50.1M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.02B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.